India Glycols Limited (NSE:INDIAGLYCO)
India
· Delayed Price · Currency is INR 2,051.00
+38.50 (1.91%)
Jun 26, 2025, 3:30 PM IST
India Glycols Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 37,683 | 32,940 | 26,509 | 28,683 | 23,170 | Upgrade
|
| Revenue Growth (YoY) | 14.40% | 24.26% | -7.58% | 23.79% | -15.30% | Upgrade
|
| Cost of Revenue | 27,697 | 21,904 | 16,207 | 19,628 | 15,354 | Upgrade
|
| Gross Profit | 9,985 | 11,036 | 10,302 | 9,055 | 7,815 | Upgrade
|
| Selling, General & Admin | 1,227 | 1,138 | 914.33 | 934.53 | 861.49 | Upgrade
|
| Other Operating Expenses | 3,649 | 5,694 | 6,103 | 4,137 | 4,062 | Upgrade
|
| Operating Expenses | 6,028 | 7,847 | 7,957 | 7,183 | 5,779 | Upgrade
|
| Operating Income | 3,957 | 3,189 | 2,345 | 1,872 | 2,036 | Upgrade
|
| Interest Expense | -1,644 | -1,051 | -850.11 | -579.92 | -713.7 | Upgrade
|
| Interest & Investment Income | - | 235.81 | 247.17 | 242.51 | 92.89 | Upgrade
|
| Earnings From Equity Investments | 464 | 166.63 | 113.72 | 208.83 | 7.19 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -189.42 | -370.44 | -190.77 | -178.57 | Upgrade
|
| Other Non Operating Income (Expenses) | 145.5 | -158.6 | -132.54 | -76.32 | -118.92 | Upgrade
|
| EBT Excluding Unusual Items | 2,923 | 2,193 | 1,353 | 1,476 | 1,125 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 1.76 | 1.34 | 1.46 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 38.85 | 14.34 | -0.9 | -0.55 | Upgrade
|
| Other Unusual Items | - | - | 281.36 | 2,213 | 80 | Upgrade
|
| Pretax Income | 2,923 | 2,233 | 1,650 | 3,690 | 1,205 | Upgrade
|
| Income Tax Expense | 614 | 503.22 | 239.63 | 394.26 | 112.76 | Upgrade
|
| Earnings From Continuing Operations | 2,309 | 1,730 | 1,410 | 3,296 | 1,092 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 102.67 | 224.05 | Upgrade
|
| Net Income to Company | 2,309 | 1,730 | 1,410 | 3,399 | 1,316 | Upgrade
|
| Minority Interest in Earnings | - | - | -159.59 | - | - | Upgrade
|
| Net Income | 2,309 | 1,730 | 1,251 | 3,399 | 1,316 | Upgrade
|
| Net Income to Common | 2,309 | 1,730 | 1,251 | 3,399 | 1,316 | Upgrade
|
| Net Income Growth | 33.48% | 38.30% | -63.19% | 158.23% | 14.79% | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 31 | Upgrade
|
| Shares Change (YoY) | 0.00% | - | - | - | - | Upgrade
|
| EPS (Basic) | 74.58 | 55.87 | 40.40 | 109.77 | 42.51 | Upgrade
|
| EPS (Diluted) | 74.58 | 55.87 | 40.40 | 109.77 | 42.51 | Upgrade
|
| EPS Growth | 33.48% | 38.30% | -63.19% | 158.23% | 14.79% | Upgrade
|
| Free Cash Flow | -3,984 | -1,144 | -1,131 | -2,639 | -115.54 | Upgrade
|
| Free Cash Flow Per Share | -128.66 | -36.95 | -36.52 | -85.23 | -3.73 | Upgrade
|
| Dividend Per Share | 10.000 | 8.000 | 7.500 | 7.500 | 6.000 | Upgrade
|
| Dividend Growth | 25.00% | 6.67% | - | 25.00% | - | Upgrade
|
| Gross Margin | 26.50% | 33.50% | 38.86% | 31.57% | 33.73% | Upgrade
|
| Operating Margin | 10.50% | 9.68% | 8.85% | 6.53% | 8.79% | Upgrade
|
| Profit Margin | 6.13% | 5.25% | 4.72% | 11.85% | 5.68% | Upgrade
|
| Free Cash Flow Margin | -10.57% | -3.47% | -4.26% | -9.20% | -0.50% | Upgrade
|
| EBITDA | 5,109 | 4,121 | 3,193 | 2,621 | 2,778 | Upgrade
|
| EBITDA Margin | 13.56% | 12.51% | 12.05% | 9.14% | 11.99% | Upgrade
|
| D&A For EBITDA | 1,152 | 931.6 | 848.19 | 749.6 | 741.28 | Upgrade
|
| EBIT | 3,957 | 3,189 | 2,345 | 1,872 | 2,036 | Upgrade
|
| EBIT Margin | 10.50% | 9.68% | 8.85% | 6.53% | 8.79% | Upgrade
|
| Effective Tax Rate | 21.00% | 22.53% | 14.52% | 10.68% | 9.36% | Upgrade
|
| Revenue as Reported | 90,535 | 79,473 | 66,655 | 66,229 | 54,427 | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.